Purpose: Women in the decade before menopause are at risk for depression. This study describes dietary factors associated with depression risk in late premenopausal women that could be modifiable with targeted interventions.
Methods: Descriptive cross-sectional study comparing a community-based sample of 342 healthy premenopausal women categorized as low-risk and high-risk for depression in a secondary analysis of dietary variables. Depression risk was estimated with the Center for Epidemiological Studies-Depression (CES-D) scale. Dietary variables were based on three random 24-hour diet recalls during a 1-week period that included an in-person visit with measures of potential covariates such as blood pressure, height, and weight for body mass index (BMI), a urine sample for follicle-stimulating hormone, demographic factors, exercise and sleep. Independent -tests were used initially to compare groups, followed by logistic regression to adjust for covariates. Statistical significance was set at ≤ 0.05.
Results: Depression risk (CES-D ≥ 16) was present in 30% of participants. Compared with the low-risk group, the high-risk group had significantly higher intake of polyunsaturated fat, omega-6 linoleic acid and sucrose, and lower intake of galactose, vitamin C, and omega-3 eicosapentaenoic acid. After adjusting for energy intake and significant covariates (income adequacy, education, race/ethnicity, marital status, BMI, exercise and sleep duration), only polyunsaturated fat, omega-6, and sucrose remained significant.
Conclusion: Depression prior to menopause is common and multifactorial. Findings support the importance of assessing saturated fats, omega-6 fatty acids, and sucrose. Attention to diet in addition to exercise and sleep may improve intervention outcomes for mental health in midlife women.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693945 | PMC |
http://dx.doi.org/10.1089/whr.2024.0107 | DOI Listing |
Nutr Res
December 2024
Faculty of Medicine, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Faculty of Medicine, Clinical Research Institute, American University of Beirut, Beirut, Lebanon.
While low dietary quality has been linked to poor mental health, evidence on more direct relations of specific dietary quality indicators, namely degrees of food processing, with mental health disorders remains limited. This study aims to investigate the association between food groups' intakes, defined based on their degree of food processing, with depression and anxiety symptoms in a sample of Lebanese adults. We hypothesized that higher intakes of ultra-processed foods (UPF) will be related to higher risk of depression and anxiety while an opposite association will be observed for unprocessed or minimally processed foods (MPF).
View Article and Find Full Text PDFBest Pract Res Clin Anaesthesiol
September 2024
Department of Anesthesiology, University Hospital Basel, Basel, Switzerland.
The issue of obesity continues to reach new levels globally, affecting individuals across the age continuum. Obesity in pregnancy is associated with myriad comorbidities which may negatively impact the fetus, particularly dysfunctional labor and failure to progress ending in unplanned cesarean delivery. Neuraxial anesthesia represents the gold standard for cesarean delivery anesthesia and is increasingly beneficial for obese patients due to the risk of difficult airway.
View Article and Find Full Text PDFPostgrad Med J
January 2025
Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Background: Smartphone overuse is associated with both psychological and physical health problems, including depression and musculoskeletal disorders. However, the association between smartphone overuse and neck pain remains unclear. We performed a meta-analysis to examine the relation between smartphone overuse and neck pain, and to identify high-risk usage patterns.
View Article and Find Full Text PDFFront Pharmacol
December 2024
Department of Clinical Psychology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Background: Deutetrabenazine is a widely used drug for the treatment of tardive dyskinesia (TD), and post-marketing testing is important. There is a lack of real-world, large-sample safety studies of deutetrabenazine. In this study, a pharmacovigilance analysis of deutetrabenazine was performed based on the FDA Adverse Event Reporting System (FAERS) database to evaluate its relevant safety signals for clinical reference.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!